Skip to Main

Kaye Foster is a Senior Advisor and Executive Coach at Boston Consulting Group. She has over 20 years of coaching experience focused on helping CEOs and senior executives navigate transformational change for the organizations they lead. Kaye’s work with C-suite executives combines the strategic context and aspirations of the business while considering the company’s stage of development and industry verticals.

Most of her recent assignments have centered on CEO transitions post-M&A for $20 billion to $30 billion market cap companies, coaching senior leaders through major org redesign and restructuring efforts, and helping leadership teams design and implement effective diversity and inclusion strategies.

Kaye is currently a member of the Board of Trustees of Stanford Health Care and the Board of Directors of Valley Care. She has served on the Board of Directors of Agios Pharmaceuticals, a leader in the fields of cancer metabolism and rare genetic disorders of metabolism, as well as the Boards of Prime Medicine and Resilience, Inc.. She recently joined Arch Ventures as a Venture Partner. In her philanthropic pursuits, Kaye chairs the Board of Trustees of the Glide Foundation in San Francisco.

Before coming to BCG, Kaye served as the SVP, Global Human Resources, for Onyx Pharmaceuticals. Prior to Onyx, she was CHRO at Johnson & Johnson where she served as a member of the company’s Executive Committee. Before that, she held executive HR roles with Pfizer, supporting its businesses in Asia, Africa, the Middle East, and Latin America.

AREAS OF EXPERTISE

EDUCATION

  • MBA, Columbia University Graduate School of Business
  • BBA, Baruch College of the City University of New York

Publications and Videos

Get Ready to Lead the Next Transformation

From sustainability to AI, operationalizing transformation is hard. BCG’s Transformation Academy brings together a top team of executive coaches to help industry leaders chart success.

How Leaders Grow

BCG’s team of executive coaches know from experience what’s it like to be a world-class leader—and what it takes to reach your fullest potential.

Close up view of the covid-19 vaccine bottle and needle

Fixing the Fallout from a Myopic Focus on Black Vaccine Hesitancy

Concerns about Black hesitancy during the rollout of the COVID-19 vaccine have distracted health officials from the real issue: equitable access.
7 leaders 7 views.jpg

7 Leaders - 7 Views. What's Critical. Leading Through the COVID19 Storm.

Ask yourself: What do I – and we as a company – stand for, and how can we act in integrity with those values? Decisions around layoffs are some of the most gut-wrenching, and will probably be a necessity given the economic impact of this pandemic. But there are a variety of ways to reduce operating costs and preserve cash without reducing headcounts.
leapfrog-succession-1694x950-tcm9-81407.jpg

Leapfrog Succession: A New Trend in Appointing CEOs?

Corporate boards seem increasingly willing to appoint CEOs who are relatively unseasoned but forward-looking executives. The success of such fast-track promotions relies heavily on a rigorous CEO-readiness program.